968 results on '"Rancati T"'
Search Results
2. Dependence of the AUC of NTCP models on the observational dose-range highlights cautions in comparison of discriminative performance
3. Survey on the interest and commitment of AIFM members to scientific activities (SicAS) – The initiative of the FutuRuS working group
4. Does multiparametric (mp) MRI and MRI-informed biopsy improve risk allocation of men at inclusion in active surveillance for low-risk prostatic cancer? Results of per-protocol population of the prospective single institution SPRINT trial
5. Real world data of active surveillance protocols in low-risk prostate cancer. Intensity of follow-up may be reduced according to a 14 years’ experience
6. Grade reclassification during active surveillance in low risk prostate cancer men selected with an MRI-informed biopsy
7. USE DOSE OF SURFACE MAPS TO IDENTIFY BLADDER SUB-REGIONS ASSOCIATED WITH LATE TOXICITIES AFTER PROSTATE CANCER RADIOTHERAPY
8. THE MICROVASCULAR HEALTH STATUS PREDICTS RADIO-INDUCES ACUTE TOXICITY IN BREAST AND PROSTATE CANCER PATIENTS
9. A FIRST PILOT EXPERIMENT FOR REPEATABILITY OF VOXEL-BASED ANALYSIS PIPELINE IN RADIATION ONCOLOGY
10. WORSENING OF 2-YEAR PATIENT-REPORTED INTESTINAL FUNCTIONALITY AFTER RADIOTHERAPY FOR PROSTATE CANCER INCLUDING PELVIC NODE IRRADIATION
11. Genetically-based Cox-NTCP models for late toxicity after prostate cancer RT
12. DOSIMETRY PREDICTORS OF LATE SKIN REACTIONS AFTER WHOLE BREAST RADIOTHERAPY ON A LARGE MONO-INSTITUTIONAL COHORT OF PATIENTS
13. ASSOCIATION OF PERSISTENT URINARY SYMPTOMS WITH QUALITY OF LIFE AFTER PROSTATE CANCER RADIOTHERAPY
14. SELECTIVE SPARING OF RECTUM/BLADDER SUB-REGIONS ASSOCIATED TO INCREASED RISK OF LATE TOXICITY AFTER PROSTATE CANCER RADIOTHERAPY BY MULTI-CRITERIA OPTIMIZATION
15. TRANSFERABILITY OF KNOWLEDGE-BASED PLAN PREDICTION MODELS: A STEP FORWARD TOWARD BENCHMARK FOR BREAST RADIOTHERAPY
16. GENETICALLY-BASED COX-NTCP MODELS FOR LATE TOXICITY AFTER PROSTATE CANCER RT
17. Predicting Acute Radio-Induced Toxicity for Head and Neck Cancer Patients: Combining Dosimetry with Biomarker Data, Disclosing a Synergistic Effect
18. Study of a Geometric Score to Identify the Increased Risk of Local Failure after SBRT for Locally Advanced Pancreatic Cancer (LAPC)
19. The Microvascular Health Status Predicts Radio-Induced Acute Toxicities in Breast, Prostate and Head and Neck Cancer Patients
20. The Microvascular Network Density and Morphology Affect the Radiotherapy Outcome at the Microscale Level: A Computational Analysis
21. A 3-Dimensional Calculation of Atmospheric Neutrino Flux
22. OC-0094 Radiobiological models for microvascular damage including functional impairment of capillary wall
23. PO-2025 Reconstructing dose distributions from manually planned electron boosts in breast radiotherapy
24. MO-0056 NTCP Models for Late Tissue Fibrosis Following Breast RT are Validated in a Large Prospective Cohort
25. MO-0475 Late toxicity-associated patient-specific subregions in plan optimization for prostate cancer
26. PD-0232 Skin Dose Predictors of Early-Late Reactions after Whole Breast RT in a Single-Center Large-Cohort
27. PO-1646 KB plan optimization models’ transferability: multi-institutional international consortia validation
28. PD-0233 One-Week External Beam Partial Breast Irradiation: Survival and Toxicity Outcomes
29. OC-0453 Dosimetry Predictors of Acute Skin Reactions after Whole Breast Radiotherapy
30. PD-0082 Interest and commitment of medical physicists to scientific activities: a national survey
31. OC-0608 Do patients with lung cancer and a genetic risk for rheumatoid arthritis have increased toxicity?
32. PO-2113 Evaluating and updating predictive models: a high-tech open platform to boost clinical translation
33. MO-0220 Two-year impact of bowel symptoms on HRQoL after RT for prostate cancer with pelvic node irradiation
34. PO-2119 Repeatability of Voxel-Based Analysis pipeline in radiation oncology: a first pilot experiment
35. PO-1956 Normal Tissue Control Probability evaluation of photon versus proton therapy for left breast cancer
36. PO-2110 Normalised odds ratios help understand the relative importance of dose in multivariable models
37. OC-0110 Head and neck adenoid cystic carcinoma treated with raster scanning carbon ion radiotherapy at CNAO
38. OC-0597 Gut Microbiota is Predictive of Radio-induced Gastrointestinal Toxicity in Prostate Cancer Patients
39. OC-0510 Genetically-based Cox-NTCP models for late toxicity after prostate cancer RT
40. PD-01.48 - WORSENING OF 2-YEAR PATIENT-REPORTED INTESTINAL FUNCTIONALITY AFTER RADIOTHERAPY FOR PROSTATE CANCER INCLUDING PELVIC NODE IRRADIATION
41. PD-01.46 - ASSOCIATION OF PERSISTENT URINARY SYMPTOMS WITH QUALITY OF LIFE AFTER PROSTATE CANCER RADIOTHERAPY
42. PC-10.1 - SURVEY ON THE INTEREST AND COMMITMENT OF AIFM MEMBERS TO SCIENTIFIC ACTIVITIES (SICAS) - THE INITIATIVE OF THE FUTURUS WORKING GROUP
43. PC-01.11 - SELECTIVE SPARING OF RECTUM/BLADDER SUB-REGIONS ASSOCIATED TO INCREASED RISK OF LATE TOXICITY AFTER PROSTATE CANCER RADIOTHERAPY BY MULTI-CRITERIA OPTIMIZATION
44. MO-02.2 - DOSIMETRY PREDICTORS OF LATE SKIN REACTIONS AFTER WHOLE BREAST RADIOTHERAPY ON A LARGE MONO-INSTITUTIONAL COHORT OF PATIENTS
45. MO-01.6 - TRANSFERABILITY OF KNOWLEDGE-BASED PLAN PREDICTION MODELS: A STEP FORWARD TOWARD BENCHMARK FOR BREAST RADIOTHERAPY
46. CO-07.2 - THE MICROVASCULAR HEALTH STATUS PREDICTS RADIO-INDUCES ACUTE TOXICITY IN BREAST AND PROSTATE CANCER PATIENTS
47. CO-04.5 - GENETICALLY-BASED COX-NTCP MODELS FOR LATE TOXICITY AFTER PROSTATE CANCER RT
48. CO-03.1 - USE DOSE OF SURFACE MAPS TO IDENTIFY BLADDER SUB-REGIONS ASSOCIATED WITH LATE TOXICITIES AFTER PROSTATE CANCER RADIOTHERAPY
49. CO-01.6 - A FIRST PILOT EXPERIMENT FOR REPEATABILITY OF VOXEL-BASED ANALYSIS PIPELINE IN RADIATION ONCOLOGY
50. Overview of the synergistic use of radiotherapy and immunotherapy in cancer treatment: current challenges and scopes of improvement
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.